back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2017-09-19 Tx date 2017-09-18 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
52 - Expiration of options
|
$7,613
+1,228 vol $6.20 each |
122,797 | |
| Filed 2017-09-19 Tx date 2017-09-18 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$4,418
+993 vol $4.45 each |
121,569 | |
| Filed 2017-09-18 Tx date 2017-09-18 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-55,170
-6,000 vol $9.20 each |
86,100 | |
| Filed 2017-06-16 Tx date 2017-06-16 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,980
-1,000 vol $7.98 each |
92,100 | |
| Filed 2017-06-13 Tx date 2017-06-13 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-15,840
-2,000 vol $7.92 each |
93,100 | |
| Filed 2017-06-08 Tx date 2017-06-08 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-15,860
-2,000 vol $7.93 each |
95,100 | |
| Filed 2017-06-06 Tx date 2017-06-06 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-15,480
-2,000 vol $7.74 each |
97,100 | |
| Filed 2017-06-03 Tx date 2017-06-01 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$3,549
+3,900 vol $0.91 each |
120,576 | |
| Filed 2017-06-03 Tx date 2017-06-01 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$3,549
+3,900 vol $0.91 each |
101,100 | |
| Filed 2017-06-02 Tx date 2017-06-02 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-15,600
-2,000 vol $7.80 each |
95,200 | |
| Filed 2016-09-29 Tx date 2016-09-29 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,800
-2,000 vol $8.40 each |
97,200 | |
| Filed 2016-03-24 Tx date 2016-03-24 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,200
-2,000 vol $7.10 each |
99,200 | |
| Filed 2016-03-23 Tx date 2016-03-23 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,200
-2,000 vol $7.10 each |
101,200 | |
| Filed 2016-03-23 Tx date 2016-03-23 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,127
-300 vol $7.09 each |
103,200 | |
| Filed 2016-03-22 Tx date 2016-03-21 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-28,160
-4,000 vol $7.04 each |
103,500 | |
| Filed 2016-03-16 Tx date 2016-03-16 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-13,740
-2,000 vol $6.87 each |
107,500 | |
| Filed 2016-03-09 Tx date 2016-03-09 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-27,776
-4,000 vol $6.94 each |
109,500 | |
| Filed 2016-02-17 Tx date 2016-02-12 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$7,613
+1,228 vol $6.20 each |
116,676 | |
| Filed 2015-06-22 Tx date 2015-06-22 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-32,560
-4,000 vol $8.14 each |
113,500 | |
| Filed 2015-06-19 Tx date 2015-06-17 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-32,040
-4,000 vol $8.01 each |
117,500 | |
| Filed 2015-06-15 Tx date 2015-06-15 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-32,040
-4,000 vol $8.01 each |
121,500 | |
| Filed 2015-05-28 Tx date 2015-05-21 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-454,350
-65,000 vol $6.99 each |
115,448 | |
| Filed 2015-05-28 Tx date 2015-05-21 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-454,350
-65,000 vol $6.99 each |
||
| Filed 2015-05-26 Tx date 2015-05-21 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-454,350
-65,000 vol $6.99 each |
115,448 | |
| Filed 2015-05-26 Tx date 2015-05-21 |
$RX
BioSyent Inc. |
Wakefield, Milt
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$454,350
+65,000 vol $6.99 each |
125,500 |